Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

NOREPINEPHRINE BITARTRATE

Standard Dose
EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE is listed in Drugs@FDA under application 219692 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NOREPINEPHRINE BITARTRATE Form and strength SOLUTION;INTRAVENOUS - EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) Sponsor SAGENT Submission history Latest submission status date: 2025-08-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE is listed in Drugs@FDA under application 219692 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NOREPINEPHRINE BITARTRATE Form and strength SOLUTION;INTRAVENOUS - EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) Sponsor SAGENT Submission history Latest submission status date: 2025-08-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE) | Drug Monograph | MedicHelpline